Potential of ion mobility-mass spectrometry for both targeted and non-targeted analysis of phase II steroid metabolites in urine

In recent years, the commercialization of hybrid ion mobility-mass spectrometers and their integration in traditional LC-MS workflows provide new opportunities to extend the current boundaries of targeted and non-targeted analyses. When coupled to LC-MS, ion mobility spectrometry (IMS) provides a no...

Full description

Bibliographic Details
Main Authors: Maykel Hernández-Mesa, Fabrice Monteau, Bruno Le Bizec, Gaud Dervilly-Pinel
Format: Article
Language:English
Published: Elsevier 2019-03-01
Series:Analytica Chimica Acta: X
Online Access:http://www.sciencedirect.com/science/article/pii/S2590134619300027
id doaj-20cb2d5352164b7ba52fbd0b2f201dec
record_format Article
spelling doaj-20cb2d5352164b7ba52fbd0b2f201dec2020-11-25T00:52:40ZengElsevierAnalytica Chimica Acta: X2590-13462019-03-011Potential of ion mobility-mass spectrometry for both targeted and non-targeted analysis of phase II steroid metabolites in urineMaykel Hernández-Mesa0Fabrice Monteau1Bruno Le Bizec2Gaud Dervilly-Pinel3Laboratoire d’Etude des Résidus et Contaminants dans les Aliments (LABERCA), Oniris, INRA UMR 1329, UBL, Nantes, F-44307, FranceLaboratoire d’Etude des Résidus et Contaminants dans les Aliments (LABERCA), Oniris, INRA UMR 1329, UBL, Nantes, F-44307, FranceLaboratoire d’Etude des Résidus et Contaminants dans les Aliments (LABERCA), Oniris, INRA UMR 1329, UBL, Nantes, F-44307, FranceCorresponding author.; Laboratoire d’Etude des Résidus et Contaminants dans les Aliments (LABERCA), Oniris, INRA UMR 1329, UBL, Nantes, F-44307, FranceIn recent years, the commercialization of hybrid ion mobility-mass spectrometers and their integration in traditional LC-MS workflows provide new opportunities to extend the current boundaries of targeted and non-targeted analyses. When coupled to LC-MS, ion mobility spectrometry (IMS) provides a novel characterization parameter, the so-called averaged collision cross section (CCS, Ω), as well as improves method selectivity and sensitivity by the separation of isobaric and isomeric molecules and the isolation of the analytes of interest from background noise. In this work, we have explored the potential and advantages of this technology for carrying out the determination of phase II steroid metabolites (i.e. androgen and estrogen conjugates, including glucuronide and sulfate compounds; n = 25) in urine samples. These molecules have been selected based on their relevance in the fields of chemical food safety and doping control, as well as in metabolomics studies. The influence of urine matrix on the CCS of steroid metabolites was evaluated in order to give more confidence to current CCS databases and support its use as complementary information to retention time (Rt) and mass spectra for compound identification. Samples were only diluted 10-fold with aqueous formic acid (0.1%, v/v) prior analysis. Only an almost insignificant effect of adult bovine urine matrix on the CCS of certain steroid metabolites was observed in comparison with calve urine matrix, which is a less complex sample. In addition, high accuracy was achieved for CCS measurements carried out over four months (ΔCCS < 1.3% for 99.8% of CCS measurements; n = 1806). Interestingly, it has been observed that signal-to-noise (S/N) ratio could be improved at least 2 or 7-fold when IMS is combined with LC-MS. In addition to the separation of isomeric steroid pairs (i.e. etiocholanolone glucuronide and epiandrosterone glucuronide, as well as 19-noretiocholanolone glucuronide and 19-norandrosterone glucuronide), steroid-based ions were also separated in the IMS dimension from co-eluting matrix compounds that presented similar mass-to-charge ratio (m/z). Finally, based on CCS measurements and as a proof of concept, 17α-boldenone glucuronide has been identified as one of the main metabolites resulted from boldione administration to calves. Keywords: Ion mobility-mass spectrometry, Collision cross section, Steroids, Phase II metabolites, Urinehttp://www.sciencedirect.com/science/article/pii/S2590134619300027
collection DOAJ
language English
format Article
sources DOAJ
author Maykel Hernández-Mesa
Fabrice Monteau
Bruno Le Bizec
Gaud Dervilly-Pinel
spellingShingle Maykel Hernández-Mesa
Fabrice Monteau
Bruno Le Bizec
Gaud Dervilly-Pinel
Potential of ion mobility-mass spectrometry for both targeted and non-targeted analysis of phase II steroid metabolites in urine
Analytica Chimica Acta: X
author_facet Maykel Hernández-Mesa
Fabrice Monteau
Bruno Le Bizec
Gaud Dervilly-Pinel
author_sort Maykel Hernández-Mesa
title Potential of ion mobility-mass spectrometry for both targeted and non-targeted analysis of phase II steroid metabolites in urine
title_short Potential of ion mobility-mass spectrometry for both targeted and non-targeted analysis of phase II steroid metabolites in urine
title_full Potential of ion mobility-mass spectrometry for both targeted and non-targeted analysis of phase II steroid metabolites in urine
title_fullStr Potential of ion mobility-mass spectrometry for both targeted and non-targeted analysis of phase II steroid metabolites in urine
title_full_unstemmed Potential of ion mobility-mass spectrometry for both targeted and non-targeted analysis of phase II steroid metabolites in urine
title_sort potential of ion mobility-mass spectrometry for both targeted and non-targeted analysis of phase ii steroid metabolites in urine
publisher Elsevier
series Analytica Chimica Acta: X
issn 2590-1346
publishDate 2019-03-01
description In recent years, the commercialization of hybrid ion mobility-mass spectrometers and their integration in traditional LC-MS workflows provide new opportunities to extend the current boundaries of targeted and non-targeted analyses. When coupled to LC-MS, ion mobility spectrometry (IMS) provides a novel characterization parameter, the so-called averaged collision cross section (CCS, Ω), as well as improves method selectivity and sensitivity by the separation of isobaric and isomeric molecules and the isolation of the analytes of interest from background noise. In this work, we have explored the potential and advantages of this technology for carrying out the determination of phase II steroid metabolites (i.e. androgen and estrogen conjugates, including glucuronide and sulfate compounds; n = 25) in urine samples. These molecules have been selected based on their relevance in the fields of chemical food safety and doping control, as well as in metabolomics studies. The influence of urine matrix on the CCS of steroid metabolites was evaluated in order to give more confidence to current CCS databases and support its use as complementary information to retention time (Rt) and mass spectra for compound identification. Samples were only diluted 10-fold with aqueous formic acid (0.1%, v/v) prior analysis. Only an almost insignificant effect of adult bovine urine matrix on the CCS of certain steroid metabolites was observed in comparison with calve urine matrix, which is a less complex sample. In addition, high accuracy was achieved for CCS measurements carried out over four months (ΔCCS < 1.3% for 99.8% of CCS measurements; n = 1806). Interestingly, it has been observed that signal-to-noise (S/N) ratio could be improved at least 2 or 7-fold when IMS is combined with LC-MS. In addition to the separation of isomeric steroid pairs (i.e. etiocholanolone glucuronide and epiandrosterone glucuronide, as well as 19-noretiocholanolone glucuronide and 19-norandrosterone glucuronide), steroid-based ions were also separated in the IMS dimension from co-eluting matrix compounds that presented similar mass-to-charge ratio (m/z). Finally, based on CCS measurements and as a proof of concept, 17α-boldenone glucuronide has been identified as one of the main metabolites resulted from boldione administration to calves. Keywords: Ion mobility-mass spectrometry, Collision cross section, Steroids, Phase II metabolites, Urine
url http://www.sciencedirect.com/science/article/pii/S2590134619300027
work_keys_str_mv AT maykelhernandezmesa potentialofionmobilitymassspectrometryforbothtargetedandnontargetedanalysisofphaseiisteroidmetabolitesinurine
AT fabricemonteau potentialofionmobilitymassspectrometryforbothtargetedandnontargetedanalysisofphaseiisteroidmetabolitesinurine
AT brunolebizec potentialofionmobilitymassspectrometryforbothtargetedandnontargetedanalysisofphaseiisteroidmetabolitesinurine
AT gauddervillypinel potentialofionmobilitymassspectrometryforbothtargetedandnontargetedanalysisofphaseiisteroidmetabolitesinurine
_version_ 1725240981301755904